Who owns QTTB?
Institutional ownership of Q32 Bio Inc. from Form 13F, Q2 2026
71 institutional managers reported holding Q32 Bio Inc. (QTTB) in Form 13F filings for Q2 2026, with 22,197,158 shares worth $283M. The largest reported holder was Orbimed Advisors LLC. Managers that filed both quarters added a net 12,768,298 shares (+135.4%). 27 opened new positions and 8 sold out.
- Funds holding
- 71
- Value held
- $283M
- New / sold out
- 27 / 8
- Net shares, same filers
- +135.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of QTTB
Share of 13F holdings is each fund's shares as a share of the 22,197,158 QTTB shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Boxer Capital Management, LLC New+$40.1M
- BVF Inc New+$29.9M
- Ra Capital Management, L.p. New+$29.7M
- Orbimed Advisors LLC Added+$23.9M
- Point72 Asset Management, L.P. New+$14.9M
- Logos Global Management LP New+$10.2M
- SummitTX Capital, L.P. New+$9.3M
- Atlas Venture Life Science Advisors, LLC Added+$8.0M
- Ikarian Capital, LLC New+$5.5M
- Woodline Partners LP New+$3.6M
Biggest sellers in Q2 2026
- Carlyle Group Inc. Trimmed-$13.3M
- Opaleye Management Inc. Trimmed-$4.1M
- ARCH Venture Management, LLC Sold out-$2.1M
- Mackenzie Financial Corp Sold out-$1.6M
- Acorn Capital Advisors, LLC Trimmed-$1.3M
- Pfizer Inc Sold out-$737K
- Renaissance Technologies LLC Trimmed-$348K
- ADAR1 Capital Management, LLC Sold out-$225K
- Cetera Investment Advisers Sold out-$133K
- EverSource Wealth Advisors, LLC Trimmed-$56K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $191M and sold $24.0M; 18 added and 13 trimmed.
Schedule 13D and 13G filings on QTTB
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16PRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2026-10-28BANK OF AMERICA CORP /DE/ SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2026-06-04BIOTECHNOLOGY VALUE FUND L P SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2026-06-04RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2026-02-21Opaleye Management Inc. SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2026-02-19Point72 Asset Management, L.P. SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2025-04-08Sio Capital Management, LLC SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
- 2025-02-10Sio Capital Management, LLC SCHEDULE 13G filed by Q32 Bio Inc.Schedule 13G
Questions about QTTB ownership
- Who owns QTTB stock?
- 71 institutional investment managers reported QTTB positions in their Form 13F filings for Q2 2026, holding 22,197,158 shares worth $283M in total. Orbimed Advisors LLC reported the largest position.
- Are funds buying or selling QTTB?
- In Q2 2026, 27 managers opened new QTTB positions, 18 added, 13 trimmed and 8 sold out. Managers that filed in both quarters added a net 12,768,298 shares.
- How current is this QTTB institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to QTTB by CUSIP. Options are left out. QTTB news and filings · QTTB insider trades · Top funds